pharma news today glp-1 obesity drugs Agonists Weight Loss Market Report, 2025-2030 GLP-1 agonists and changes in

PMID: 19231263 | doi:10.1016/j.ghir.2009.01.001 Venkova K et al

A large study of 2000 patients without diabetes showed that using Ozempic/Wegovy in addition to diet and exercise for 68 weeks led to a 15% weight loss (1/3 of the participants lost up to 20% of their starting weight.) Those in the control group that were only coached on the lifestyle changes lost 2.4% of their weight

cAMP correlated with taurine (r = 0.58

GLP-1 medication is most effective when combined with nutrition changes, physical activity, strength training, sleep improvement, and long-term behavior planning

Here's what they said

Studies suggest this dual approach produces a 3-5 fold increase in growth hormone release compared to either peptide alone, while maintaining natural pulsatile secretion patterns